Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.

Cao, Bin; Hayden, Frederick G

Cao, Bin; Hayden, Frederick G.

Afiliación

Cao B; Department of Pulmonary and Critical Care Medicine, Center for Respiratory Diseases, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Ele
Hayden FG; Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.

Lancet ; 396(10259): 1310-1311, 2020 10 24.

Article en En | MEDLINE | ID: mdl-33031761

Asunto(s)

COVID-19; Antivirales/uso terapéutico; Hospitalización; Humanos; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google